People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clementia Pharmaceuticals Inc. | — | Pharmaceuticals | Series C | $60.0M | $2.1B | 2015 |
Francois P. Nader at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Francois P. Nader on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David P. Bonita | 1 | 2 |
| Jean-Francois P. Pariseau | 1 | 1 |
| Michael Roy Singer | 1 | 1 |
| Robert P. Heft | 1 | 1 |
| Clarissa Desjardins | 1 | 1 |
| Eric P. Grinstead | 1 | 1 |
| Jeffrey Roy Packman | 1 | 1 |
| Donna Roy Grogan | 1 | 1 |
| Allan P. Mandelzys | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.